Name
pertsts3psg
Label
Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Description
Conventionally, total sleep duration would be called total sleep time (TST).
Units
percentage
Type
numeric
Tags
Visit (Number) vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
Diagnostic Visit (DX) | 1,223 | 2.5 | ± 4.8 | 0.0 | 0.0 | 35.1 | 293 | 1,516 |
CPAP Titration Visit (CPAP) | 1,065 | 3.5 | ± 6.2 | 0.0 | -2.0 | 38.8 | 451 | 1,516 |
Two Month Post-CPAP Neurocognitive Visit (2M) | 879 | 3.1 | ± 5.4 | 0.0 | 0.0 | 41.4 | 637 | 1,516 |
Four Month Post-CPAP Neurocognitive Visit (4M) | - | - | - | - | - | - | 1,516 | 1,516 |
Six Month Post-CPAP Neurocognitive Visit (6M) | 849 | 2.8 | ± 5.1 | 0.0 | 0.0 | 26.8 | 667 | 1,516 |
Gender vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,223 | 2.5 | ± 4.8 | 0.0 | 0.0 | 35.1 | 293 | 1,516 |
Male | 783 | 2.1 | ± 4.4 | 0.0 | 0.0 | 35.1 | 175 | 958 |
Female | 440 | 3.3 | ± 5.4 | 0.3 | 0.0 | 30.7 | 118 | 558 |
Gender vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,065 | 3.5 | ± 6.2 | 0.0 | -2.0 | 38.8 | 451 | 1,516 |
Male | 699 | 3.0 | ± 5.9 | 0.0 | -2.0 | 38.8 | 259 | 958 |
Female | 366 | 4.4 | ± 6.7 | 0.5 | 0.0 | 38.2 | 192 | 558 |
Gender vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 879 | 3.1 | ± 5.4 | 0.0 | 0.0 | 41.4 | 637 | 1,516 |
Male | 572 | 2.5 | ± 5.0 | 0.0 | 0.0 | 41.4 | 386 | 958 |
Female | 307 | 4.0 | ± 6.0 | 0.4 | 0.0 | 30.9 | 251 | 558 |
Gender vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 849 | 2.8 | ± 5.1 | 0.0 | 0.0 | 26.8 | 667 | 1,516 |
Male | 552 | 2.2 | ± 4.6 | 0.0 | 0.0 | 26.1 | 406 | 958 |
Female | 297 | 3.9 | ± 5.8 | 0.4 | 0.0 | 26.8 | 261 | 558 |
Race/Ethnicity vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,223 | 2.5 | ± 4.8 | 0.0 | 0.0 | 35.1 | 293 | 1,516 |
Native American | 20 | 2.0 | ± 4.7 | 0.05 | 0.0 | 14.5 | 8 | 28 |
Asian | 73 | 2.4 | ± 4.8 | 0.0 | 0.0 | 20.5 | 16 | 89 |
Black | 120 | 1.8 | ± 3.5 | 0.0 | 0.0 | 17.8 | 52 | 172 |
Hispanic | 84 | 2.6 | ± 4.1 | 0.3 | 0.0 | 21.2 | 32 | 116 |
White | 918 | 2.6 | ± 5.0 | 0.1 | 0.0 | 35.1 | 184 | 1,102 |
Other | 8 | 2.2 | ± 3.4 | 0.2 | 0.0 | 9.1 | 1 | 9 |
Race/Ethnicity vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,065 | 3.5 | ± 6.2 | 0.0 | -2.0 | 38.8 | 451 | 1,516 |
Native American | 17 | 4.8 | ± 7.8 | 0.0 | 0.0 | 25.8 | 11 | 28 |
Asian | 60 | 4.4 | ± 7.9 | 0.0 | 0.0 | 36.7 | 29 | 89 |
Black | 97 | 1.6 | ± 3.7 | 0.0 | 0.0 | 17.2 | 75 | 172 |
Hispanic | 72 | 3.2 | ± 5.1 | 0.4 | 0.0 | 24.0 | 44 | 116 |
White | 814 | 3.6 | ± 6.3 | 0.0 | -2.0 | 38.8 | 288 | 1,102 |
Other | 5 | 0.7 | ± 1.4 | 0.1 | 0.0 | 3.2 | 4 | 9 |
Race/Ethnicity vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 879 | 3.1 | ± 5.4 | 0.0 | 0.0 | 41.4 | 637 | 1,516 |
Native American | 13 | 4.0 | ± 7.9 | 0.0 | 0.0 | 24.9 | 15 | 28 |
Asian | 49 | 3.7 | ± 4.6 | 0.9 | 0.0 | 14.6 | 40 | 89 |
Black | 77 | 2.2 | ± 5.4 | 0.0 | 0.0 | 30.9 | 95 | 172 |
Hispanic | 65 | 3.9 | ± 6.0 | 0.0 | 0.0 | 21.7 | 51 | 116 |
White | 672 | 3.0 | ± 5.4 | 0.0 | 0.0 | 41.4 | 430 | 1,102 |
Other | 3 | 1.3 | ± 2.3 | 0.0 | 0.0 | 4.0 | 6 | 9 |
Race/Ethnicity vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Percentage of stage 3 sleep among total sleep duration from type I polysomnography
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 849 | 2.8 | ± 5.1 | 0.0 | 0.0 | 26.8 | 667 | 1,516 |
Native American | 13 | 4.0 | ± 6.4 | 0.3 | 0.0 | 19.5 | 15 | 28 |
Asian | 50 | 4.8 | ± 6.2 | 2.4 | 0.0 | 23.3 | 39 | 89 |
Black | 75 | 1.2 | ± 2.8 | 0.0 | 0.0 | 14.1 | 97 | 172 |
Hispanic | 61 | 3.1 | ± 4.9 | 0.0 | 0.0 | 18.5 | 55 | 116 |
White | 647 | 2.8 | ± 5.2 | 0.0 | 0.0 | 26.8 | 455 | 1,102 |
Other | 3 | 3.1 | ± 2.9 | 3.8 | 0.0 | 5.6 | 6 | 9 |